Literature DB >> 24711076

Does rebamipide prevent gastric mucosal injury in patients taking aspirin and clopidogrel?

Mitsushige Sugimoto1, Takahiro Uotani, Takahisa Furuta.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24711076     DOI： 10.1007/s10620-014-3145-z

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  17 in total

1.  Clopidogrel with or without omeprazole in coronary artery disease.

Authors:  Deepak L Bhatt; Byron L Cryer; Charles F Contant; Marc Cohen; Angel Lanas; Thomas J Schnitzer; Thomas L Shook; Pablo Lapuerta; Mark A Goldsmith; Loren Laine; Benjamin M Scirica; Sabina A Murphy; Christopher P Cannon
Journal:  N Engl J Med       Date:  2010-10-06       Impact factor: 91.245

2.  Esomeprazole with aspirin versus clopidogrel for prevention of recurrent gastrointestinal ulcer complications.

Authors:  Kam-Chuen Lai; Kent-Man Chu; Wai-Mo Hui; Benjamin Chun-Yu Wong; Wai-Ka Hung; Ching-Kong Loo; Wayne Hsing-Ching Hu; Annie On-On Chan; Ka-Fai Kwok; Tang-Tat Fung; John Wong; Shiu-Kum Lam
Journal:  Clin Gastroenterol Hepatol       Date:  2006-06-22       Impact factor: 11.382

3.  A randomized, double-blind, placebo-controlled study of rebamipide for gastric mucosal injury taking aspirin with or without clopidogrel.

Authors:  Katsuyuki Tozawa; Tadayuki Oshima; Takuya Okugawa; Tomohiro Ogawa; Yoshio Ohda; Toshihiko Tomita; Nobuyuki Hida; Hirokazu Fukui; Kazutoshi Hori; Jiro Watari; Shiro Nakamura; Hiroto Miwa
Journal:  Dig Dis Sci       Date:  2014-08       Impact factor: 3.199

4.  Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding.

Authors:  Francis K L Chan; Jessica Y L Ching; Lawrence C T Hung; Vincent W S Wong; Vincent K S Leung; Nelson N S Kung; Aric J Hui; Justin C Y Wu; Wai K Leung; Vivian W Y Lee; Kenneth K C Lee; Yuk T Lee; James Y W Lau; Ka F To; Henry L Y Chan; S C Sydney Chung; Joseph J Y Sung
Journal:  N Engl J Med       Date:  2005-01-20       Impact factor: 91.245

5.  Effects of very low dose daily, long-term aspirin therapy on gastric, duodenal, and rectal prostaglandin levels and on mucosal injury in healthy humans.

Authors:  B Cryer; M Feldman
Journal:  Gastroenterology       Date:  1999-07       Impact factor: 22.682

6.  A new model of gastric bleeding induced in rats by aspirin plus clopidogrel under stimulation of acid secretion. Prophylactic effects of antiulcer drugs.

Authors:  S Takayama; C Izuhara; N Yamada; S Yamanaka; E Hashimoto; S Kaneko; K Takeuchi
Journal:  J Physiol Pharmacol       Date:  2012-02       Impact factor: 3.011

7.  Gastroduodenal tolerance of 75 mg clopidogrel versus 325 mg aspirin in healthy volunteers. A gastroscopic study.

Authors:  F T Fork; P Lafolie; E Tóth; F Lindgärde
Journal:  Scand J Gastroenterol       Date:  2000-05       Impact factor: 2.423

Review 8.  Antiplatelet therapy and proton pump inhibition: cause for concern?

Authors:  Jeremiah P Depta; Deepak L Bhatt
Journal:  Curr Opin Cardiol       Date:  2012-11       Impact factor: 2.161

9.  Famotidine for the prevention of peptic ulcers and oesophagitis in patients taking low-dose aspirin (FAMOUS): a phase III, randomised, double-blind, placebo-controlled trial.

Authors:  Ali S Taha; Caroline McCloskey; Rakesh Prasad; Vladimir Bezlyak
Journal:  Lancet       Date:  2009-07-03       Impact factor: 79.321

10.  Preliminary trial of rebamipide for prevention of low-dose aspirin-induced gastric injury in healthy subjects: a randomized, double-blind, placebo-controlled, cross-over study.

Authors:  Shouko Ono; Mototsugu Kato; Aki Imai; Takeshi Yoshida; Jyojyo Hirota; Tamotsu Hata; Kikuko Takagi; Go Kamada; Yuji Ono; Manabu Nakagawa; Souichi Nakagawa; Yuichi Shimizu; Hiroshi Takeda; Masahiro Asaka
Journal:  J Clin Biochem Nutr       Date:  2009-08-28       Impact factor: 3.114
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.